DocDollars

Astellas Pharma Us Inc

IL · United States · Reporting entity ID 100000000137

Total reported 2019–2025
$46.8M
#185 of 2,960 reporting companies — 0.1% of all reported industry payments
$46.8M in general payments across 755,720 records.

How it breaks down

General payments $46,786,131

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Astellas Pharma Us Inc reported $46.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #185 of 2,960 reporting companies. All of it was general payments such as consulting, speaking, food and travel. 755,720 general payment records were filed.

Common questions about Astellas Pharma Us Inc

How much has Astellas Pharma Us Inc paid US doctors?

Astellas Pharma Us Inc reported $46,786,131 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $46,786,131 in general payments.

How does Astellas Pharma Us Inc rank among drug and device companies?

It ranks #185 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Astellas Pharma Us Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.